View in EDS

Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?

Saved in:
Bibliographic Details
Title: Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
Authors: van Donge T; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Brizzi F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Caruso A; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Fueth M; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com., Steiert B; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.
Source: Translational vision science & technology [Transl Vis Sci Technol] 2023 Apr 03; Vol. 12 (4), pp. 9.
Publication Type: Letter
Journal Info: Publisher: Association for Research in Vision and Ophthalmology Country of Publication: United States NLM ID: 101595919 Publication Model: Print Cited Medium: Internet ISSN: 2164-2591 (Electronic) Linking ISSN: 21642591 NLM ISO Abbreviation: Transl Vis Sci Technol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37040126
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+Donge+T%22">van Donge T</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.<br /><searchLink fieldCode="AU" term="%22Brizzi+F%22">Brizzi F</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.<br /><searchLink fieldCode="AU" term="%22Caruso+A%22">Caruso A</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.<br /><searchLink fieldCode="AU" term="%22Fueth+M%22">Fueth M</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.<br /><searchLink fieldCode="AU" term="%22Steiert+B%22">Steiert B</searchLink>; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland. e-mail: tamara.van_donge@roche.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101595919%22">Translational vision science & technology</searchLink> [Transl Vis Sci Technol] 2023 Apr 03; Vol. 12 (4), pp. 9.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Letter
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Association+for+Research+in+Vision+and+Ophthalmology%22">Association for Research in Vision and Ophthalmology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101595919 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-2591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221642591%22">21642591 </searchLink><i>NLM ISO Abbreviation: </i>Transl Vis Sci Technol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37040126
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1167/tvst.12.4.9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9
    Titles:
      – TitleFull: Are Ocular and Serum Half-Lives After Ranibizumab Intravitreal Injection Dependent on Dose?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van Donge T
      – PersonEntity:
          Name:
            NameFull: Brizzi F
      – PersonEntity:
          Name:
            NameFull: Caruso A
      – PersonEntity:
          Name:
            NameFull: Fueth M
      – PersonEntity:
          Name:
            NameFull: Steiert B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 04
              Text: 2023 Apr 03
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2164-2591
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Translational vision science & technology
              Type: main
ResultId 1